Cite
HARVARD Citation
Belli, A. et al. (n.d.). Neoadjuvant Folfiri+Bevacizumab in resectable liver metastases from CRC: results and comparison of PET/CT scan vs RECIST in predicting outcome. HPB. pp. S801-S802. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Belli, A. et al. (n.d.). Neoadjuvant Folfiri+Bevacizumab in resectable liver metastases from CRC: results and comparison of PET/CT scan vs RECIST in predicting outcome. HPB. pp. S801-S802. [Online].